Whereas the putative mechanism of action of IV vitamin C as an ESA adjuvant is an increase in the release of iron from ferritin and the reticuloendothelial system and increased iron utilization during heme synthesis, none of the studies reviewed showed reduced utilization of administered iron therapy
CagriSema: This Novo Nordisk combination is a fixed-dose co-formulation of the GLP-1 agonist semaglutide and the long-acting amylin analogue cagrilintide
Neither is universally best. The better question is which one fits your situation and thats a medical decision, not a coin flip
Medications Semaglutide, known by the brand name Wegovy, and liraglutide (Saxenda) have been specifically approved for weight loss in obesity, in combination with lifestyle changes
when untreated it is usually progressive
Its very unusual to see the extended shortage of a multi-billion dollar drug, leading to the funky dynamics were seeing DTC telehealth players (and in-person med spas, other wellness facilities) want to maximize their economics by expanding access to acquire/grow subscriber bases
